Qiagen (NYSE:QGEN) Price Target Raised to $50.00

Дата публикации: 10-08-2026 05:36:49

Qiagen (NYSE:QGEN – Free Report) had its price objective boosted by JPMorgan Chase & Co. from $45.00 to $50.00 in a research note published on Friday morning,Benzinga reports. They currently have an overweight rating on the stock. Other analysts also recently issued reports about the company. Weiss Ratings downgraded Qiagen from a “hold (c-)” rating […]

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Genpact (NYSE:G) Price Target Raised to $45.00	0	14.26	10-08-2026
2	TG Therapeutics (NASDAQ:TGTX) Price Target Raised to $72.00	0	13.04	10-08-2026
3	Cadre (NYSE:CDRE) Price Target Raised to $45.00	0	13.85	10-08-2026
4	Target (NYSE:TGT) Price Target Raised to $157.00	0	13.85	10-08-2026
5	Allient (NASDAQ:ALNT) Price Target Raised to $120.00	0	13.06	10-08-2026
6	JFrog (NASDAQ:FROG) Price Target Raised to $115.00	0	14.6	10-08-2026
7	Royalty Pharma (NASDAQ:RPRX) Price Target Raised to $62.00	0	13.82	10-08-2026
8	Replimune Group (NASDAQ:REPL) Price Target Raised to $20.00	0	13.83	10-08-2026
9	Banco De Chile (NYSE:BCH) Price Target Raised to $45.00	0	14.2	10-08-2026
10	Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target Raised to $146.00	0	14.22	10-08-2026

Классификация: . Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 14.26. Источник: www.americanbankingnews.com.